Additionally, no association between NEDD4 expression and OS was observed in Her2-positive BC patients (Additional file 5: Figure S4c, P = 0.0702), which is consistent with a previous publication showing that NEDD4 expression was not associated with clinical outcomes in Her2-positive BC patients [27]. The gene discussed is ERBB2; the disease is breast cancer.